Familial thoracic aortic aneurysms

Current Opinion in Cardiology

Volumn 29, Issue 6, 2014, Pages 492-498

  Jondeau, Guillaume ^a   Boileau, Catherine ^b  

^a Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^b Bichat AP HP   (France)

Author keywords

aorta; Marfan; transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; DNA;

ACTA2 GENE; ANEURYSM; AORTA ANEURYSM; BONE DISEASE; DIGESTIVE SYSTEM DISEASE; DISEASE CLASSIFICATION; EXTRACELLULAR MATRIX; EYE DISEASE; FAMILIAL THORACIC AORTIC ANEURYSM; FBN1 GENE; GENE; GENETIC CODE; GENETIC DISORDER; GENOTYPE; HUMAN; IMMUNOPATHOLOGY; MARFAN SYNDROME; MOLECULE; MYH11 GENE; MYLK GENE; NEUROLOGIC DISEASE; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; POLYGENIC DISEASE; PRIORITY JOURNAL; PRKG1 GENE; REVIEW; RISK; SMAD3 GENE; SMAD4 GENE; SMOOTH MUSCLE FIBER; TGFB2 GENE; THORAX DISEASE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; THORACIC AORTA ANEURYSM; VASCULAR SMOOTH MUSCLE;

AORTIC ANEURYSM, THORACIC; DNA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUSCLE, SMOOTH, VASCULAR; MUTATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84927750996     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000114     Document Type: Review

References (34)

1. Jondeau G, Detaint D, Tubach F, et al. Aortic event rate in the Marfan population: a cohort study. Circulation 2012; 125:226-232.
2. Kunkala MR, Schaff HV, Li Z, et al. Mitral valve disease in patients with Marfan syndrome undergoing aortic root replacement. Circulation 2013; 128 (Suppl. 1):S243-S247.
3. Cecchi A, Ogawa N, Martinez HR, et al. Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome. Am J Med Genet A 2013; 161:2305-2310.
4. Van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 2011; 43:121-126.
5. Van der Linde D, van de Laar IM, Bertoli-Avella AM, et al. Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol 2012; 60:397-403.
6. Aubart M, Gobert D, Aubart-Cohen F, et al. Early-onset osteoarthritis, Charcot-Marie-Tooth like neuropathy, autoimmune features, multiple arterial aneurysms and dissections: an unrecognized and life threatening condition. PLoS One 2014; 9:e96387.
7. Wischmeijer A, Van Laer L, Tortora G, et al. Thoracic aortic aneurysm in infancy in aneurysms-osteoarthritis syndrome due to a novel SMAD3 mutation: further delineation of the phenotype. Am J Med Genet A 2013; 161A:1028-1035.
8. Fitzgerald KK, Bhat AM, Conard K, et al. Novel SMAD3 mutation in a patient with hypoplastic left heart syndrome with significant aortic aneurysm. Case Rep Genet 2014; 2014:591516.
9. Teekakirikul P, Milewicz DM, Miller DT, et al. Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations. Am J Med Genet A 2013; 161A:185-191.
10. Boileau C, Guo DC, Hanna N, et al. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 2012; 44:916-921.
11. Lindsay ME, Schepers D, Bolar NA, et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 2012; 44:922-927.
12. Amans MR, Stout C, Fox C, et al. Cerebral arteriopathy associated with Arg179His ACTA2 mutation. J Neurointerv Surg 2013. [Epub ahead of print]
13. Guo DC, Regalado E, Casteel DE, et al. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet 2013; 93:398-404.
14. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355:788-798.
15. Attias D, Stheneur C, Roy C, et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 2009; 120:2541-2549.
16. Pyeritz RE. Heritable thoracic aortic disorders. Curr Opin Cardiol 2014; 29:97-102.
17. Rajeshkannan R, Kulkarni C, Kappanayil M, et al. Imaging findings in a distinct lethal inherited arteriopathy syndrome associated with a novel mutation in the FBLN4 gene. Eur Radiol 2014; 24:1742-1748.
18. Pannu H, Fadulu VT, Chang J, et al. Mutations in transforming growth factorbeta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005; 112:513-520.
19. Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, et al. TGFb receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med 2013; 5:195ra94.
20. Tran-Fadulu V, Pannu H, Kim DH, et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 2009; 46:607-613.
21. Arbustini E, Narula N. Extra-aortic identifiers to guide genetic testing in familial thoracic aortic aneurysms and dissections syndromes: it is all about the company one keeps. J Am Coll Cardiol 2012; 60:404-407.
22. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312:117-121.
23. Gallo EM, Loch DC, Habashi JP, et al. Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest 2014; 124:448-460.
24. Gomez D, Kessler K, Michel JB, Vranckx R. Modifications of chromatin dynamics control Smad2 pathway activation in aneurysmal smooth muscle cells. Circ Res 2013; 113:881-890.
25. Li W, Li Q, Jiao Y, et al. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest 2014; 124:755-767.
26. Humphrey JD, Milewicz DM, Tellides G, Schwartz MA. Cell biology. Dysfunctional mechanosensing in aneurysms. Science 2014; 344:477-479.
27. Lacro RV, Guey LT, Dietz HC, et al., Pediatric Heart Network Investigators. Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy. Am Heart J 2013; 165:828-835.
28. Groenink M, den Hartog AW, Franken R, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 2013; 34:3491-3500.
29. Gomez D, Kessler K, Borges LF, et al. Smad2-dependent protease nexin-1 overexpression differentiates chronic aneurysms from acute dissections of human ascending aorta. Arterioscler Thromb Vasc Biol 2013; 33:2222-2232.
30. Lemaire SA, McDonald ML, Guo DC, et al. Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet 2011; 43:996-1000.
31. Iakoubova OA, Tong CH, Rowland CM, et al. Genetic variants in FBN-1 and risk for thoracic aortic aneurysm and dissection. PLoS One 2014; 9:e91437.
32. Aref-Eshghi E, Zhang Y, Hart D, et al. SMAD3 is associated with the total burden of radiographic osteoarthritis: the Chingford study. PLoS One 2014; 9:e97786.
33. Verma S, Siu SC. Aortic dilatation in patients with bicuspid aortic valve. N Engl J Med 2014; 370:1920-1929.
34. Detaint D, Michelena HI, Nkomo VT, et al. Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy. Heart 2014; 100:126-134.